AMVAC Chemical licenses Bio-Rational Larvicide from Summit Chemical

American Vanguard Corporation AVD announced today that its wholly owned subsidiary AMVAC Chemical Corporation has licensed rights to Summit Chemical Corporation's Bti Briquets for the global professional mosquito larvicide market. Bti Briquets are a unique, sustained release formulation of the naturally occurring bacterium Bacillus thuringiensis israelensis (Bti) which is widely accepted as one of the safest bio-rational larvicides available today. This product provides a versatile, efficient, cost-effective and environmentally compliant treatment which has contributed to successful larvicide control for more than three decades in U.S. and international public health markets. Vince Pascarelli, AMVAC's Director of International Business Development commented: “This is a strategic growth area for AMVAC, and we are pleased to be aligned with Summit, a well-respected leader in the production and supply of mosquito larvicides. This agreement will form the cornerstone of a strategic partnership with Summit which is expected to provide AMVAC with a pipeline of new larvicides manufactured by Summit for the public health mosquito control market.”